Hepatitis D virus infection triggers CXCL9-11 upregulation in hepatocytes and liver infiltration of CXCR3+ CD4 T cells
Jan-Hendrik Bockmann,
Lena Allweiss,
Annika Volmari,
David da Fonseca Araújo,
Matin Kohsar,
Anastasia Hyrina,
Janine Kah,
Zhijuan Song,
Josolyn Chan,
Katja Giersch,
Tassilo Volz,
Marc Lütgehetmann,
Jeffrey J. Wallin,
Dmitry Manuilov,
Meghan M. Holdorf,
Simon P. Fletcher,
Ansgar W. Lohse,
Antonio Bertoletti,
Julian Schulze zur Wiesch,
Maura Dandri
Affiliations
Jan-Hendrik Bockmann
Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; German Center for Infection Research (DZIF), Hamburg-Lübeck-Borstel-Riems site, Germany; Corresponding author. Address: Department of Internal Medicine, Center for Internal Medicine, University Medical Center Hamburg-Eppendorf, Martinistr. 52, D-20246 Hamburg, Germany. Tel.: +49 40 7410 55662; fax: +49 40 7410 58531.
Lena Allweiss
Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; German Center for Infection Research (DZIF), Hamburg-Lübeck-Borstel-Riems site, Germany
Annika Volmari
Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; German Center for Infection Research (DZIF), Hamburg-Lübeck-Borstel-Riems site, Germany
David da Fonseca Araújo
Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Matin Kohsar
Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Center for Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
Anastasia Hyrina
Gilead Sciences, Foster City, CA, USA
Janine Kah
Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Center of Internal Medicine II, Brandenburg Medical School Theodor Fontane, Brandenburg an der Havel, Germany
Zhijuan Song
Gilead Sciences, Foster City, CA, USA
Josolyn Chan
Gilead Sciences, Foster City, CA, USA
Katja Giersch
Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Department of Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Tassilo Volz
Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; German Center for Infection Research (DZIF), Hamburg-Lübeck-Borstel-Riems site, Germany
Marc Lütgehetmann
German Center for Infection Research (DZIF), Hamburg-Lübeck-Borstel-Riems site, Germany; Department of Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Jeffrey J. Wallin
Gilead Sciences, Foster City, CA, USA
Dmitry Manuilov
Gilead Sciences, Foster City, CA, USA
Meghan M. Holdorf
Gilead Sciences, Foster City, CA, USA
Simon P. Fletcher
Gilead Sciences, Foster City, CA, USA
Ansgar W. Lohse
Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; German Center for Infection Research (DZIF), Hamburg-Lübeck-Borstel-Riems site, Germany
Antonio Bertoletti
Emerging Infectious Disease Program, Duke-NUS Medical School, Singapore
Julian Schulze zur Wiesch
Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; German Center for Infection Research (DZIF), Hamburg-Lübeck-Borstel-Riems site, Germany
Maura Dandri
Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; German Center for Infection Research (DZIF), Hamburg-Lübeck-Borstel-Riems site, Germany
Background & Aims: The role of hepatocytes in producing chemokines and triggering liver inflammation and damage in chronic hepatitis D (CHD) is not fully understood. Herein, we investigated the contribution of primary human hepatocytes (PHHs) infected with HDV in triggering inflammation by producing the chemokines CXCL9–11. Methods: We performed quantitative PCR, RNA in situ hybridisation, activation-induced marker (AIM) assays, and FACS analysis to investigate the CXCR3/CXCL9–11 receptor/ligand axis of T cells in peripheral blood and livers from patients with chronic hepatitis B (n = 27 and 18, respectively) and CHD (n = 20 and 18, respectively). Chemokine expression was investigated in cultured HDV-infected PHHs and in livers of HBV- or HBV/HDV-infected humanised mice in the presence or absence of adoptively transferred human immune cells (n = 35 in total). Results: In patient and chimeric mouse livers, higher expression levels of CXCL9–11 were found in an HBV/HDV-coinfected vs. HBV-mono-infected setting. Similarly, high levels of CXCL9–11 were observed in HDV-infected PHHs in vitro. Analysis by RNA in situ hybridisation on patient livers revealed that HDV-infected hepatocytes were a significant contributor to the chemokine expression. The corresponding chemokine receptor CXCR3 was found upregulated specifically on peripheral bulk CD4 T cells of patients with CHD. CXCR3 upregulation was unspecific and was not detected on HDAg- or HBsAg-specific CD4 T cells by activation-induced marker assay. Lastly, adoptive transfer of human T cells in humanised mice led to recruitment of non-HBV/HDV-specific CD4+ T cells only in the setting of HBV/HDV coinfection, but not in HBV-mono-infected mice. Conclusions: HDV infection upregulated the intrahepatic expression of the CXCL9–11/CXCR3 receptor/ligand axis. Higher amounts of HBV/HDV-unspecific CD4 T cells expressing CXCR3 may contribute to the aggravated liver inflammation frequently observed in patients with CHD. Impact and implications: Chronic hepatitis D (CHD) causes the most severe form of viral hepatitis, and treatment options are still limited; therefore, a more precise understanding of CHD immunopathology is needed. In this study, we demonstrated that HDV infection triggers CXCL9–11 expression in hepatocytes and liver infiltration of CXCR3-expressing CD4 T cells in preclinical models as well as patient biopsies. Because recruitment of Th1-polarised CD4 T cells to the liver has been also described for other severe liver diseases, such as autoimmune hepatitis, it may represent an important mechanism of aggravating liver diseases. The data of this study set hereby the basis for future studies analysing phenotype and function of intrahepatic T cells in CHD.